Services aux conférences Mandl

Résumé: The 7 th European Symposium on Biochemical Engineering Science will take place in the beautiful town of Faro at the Algarve Coastline in Portugal from 7 – 10 September 2008. The symposium is jointly organised by the IBB-Institutes of Biotechnology and Bioengineering at Faro and Lisbon University and DECHEMA, Frankfurt. It is our great pleasure to invite you to participate and to present your latest work and results. The ESBES Symposium Series has developed to the leading platform for the community over the last years which provides the opportunity for biochemical scientists and engineers but also for researchers of adjacent fields to exchange their experiences. Looking at the conference topics you will see that all areas of the discipline are covered. Workshops on new and promising technologies complete the programme.

Résumé: The Extremophiles 2008 meeting will be held in Cape Town. Set on the southern tip of Africa and surrounded by sea, mountains and vineyards, this beautiful city is a gateway to exploring the wonders of Southern Africa. Extremophiles, organisms thriving in extreme environments, offer a challenge to understanding the fundamentals of molecular and cellular function, and opportunities for sustainable exploitation.

This conference will encompass the latest research developments in a broad range of subjects including extremophile molecular ecology, metagenomics, physiology, genetics, protein structure and function and biotechnology.

Résumé: Intermediate filament (IF) proteins are encoded by one of the largest gene families in man. They have attracted considerable attention because mutations in IF genes cause, according to their tissue-specific expression, a large variety of severe human diseases. Most notably, mutations affecting the nuclear intermediate filament proteins lamin A and C lead to a stunning multitude of disease entities ranging from muscular dystrophies to premature ageing. In order to obtain more insight into IF-dependent cellular functions and disease entities, various cell culture systems and animal models, in particular transgenic mice, have been generated. Complementary to this field-wide “bench-to-bed” enterprise an arsenal of biophysical techniques is being applied to IFs aimed at dissecting the structure, assembly and mechanics of single filaments at atomic detail.

Résumé: Mehr Rechtssicherheit in nur 3 Abenden Eine schlecht vorbereitete Vertragsgestaltung kann im Streitfall ein erhebliches Haftungsrisiko sowie finanzielle Risiken für Ihr Unternehmen nach sich ziehen. Entsprechende Kenntnisse und geschickte Kniffe erleichtern Ihnen den Umgang mit Verträgen im täglichen Geschäftsleben. Dieser modular aufgebaute Workshop wird Ihnen helfen, sicheres Handeln im Vertrags- und Arbeitsrecht zu erlangen um auch in Zukunft Fehler zu vermeiden. Die Themen werden dabei anhand von anschaulichen Beispielen in der Nano- und Biotechnologiebranche erläutert. Zielpublikum Inhaber/Geschäftsführer, Führungspersonal von Firmen in der Nano- und Biotechnologiebranche Inhalte 1. Abend: Rechtssichere Vertragsgestaltungen • Geheimhaltungsvereinbarungen, Letter of Intent, Kooperationen • Gewährleistung, Zahlungsverzug • Allgemeine Geschäftsbedingungen 2. Abend: Arbeitsrecht für Unternehmer • Das neue Gleichbehandlungsgesetz (AGG) • Arbeitsverträge gestalten • Kü

Résumé: 'International Life Sciences Student's Conference Warsaw 2008' that will take place from 10th to 14th September 2008 at the University of Warsaw (UW) and Warsaw University of Life Sciences (SGGW). The conference is dedicated for BSc, MSc and PhD students from all over the world that will have the opportunity to present results of their own research in the field of life sciences (e.g. molecular biology, biotechnology, general biology, disease prevention, human and animal wellness,environmental protection, alternative energy sources).

Résumé: Bioscience is changing rapidly, becoming more quantitative and predictive in nature, with increasing inputs from the physical sciences, engineering, computation and mathematics. At the core of this wave of change is the development of new technology and biophysical methods, spanning nanotechnology, structural analysis, chemical biology, computational biology and analytical science. The changing nature of bioscience is reflected in the rapid growth of fields such as systems and synthetic biology, which are based on precise analytical approaches as well as rigorous design and modelling.

Résumé: Presenting ALL NEW data on design and validation of assays, pre-clinical and clinical developments, regulatory requirements, risk management and formulation. Join us in Hamburg to hear presentations on how to successfully develop screening, confirmatory and neutralising assays. Our interactive panel sessions will ensure you gain the most from this 4 day event. Plus, don’t miss our 14 case studies; learn from those with hands-on, practical experience and take this back to your company. Programme highlights for 2008: • Genentech, Pfizer and The Health Protection Agency present detailed case studies on neutralising assays. This year the design and validation of assays have been split into two separate sessions so that you can gain an in-depth and thorough understanding of this challenging area. With a whole day dedicated to this hot topic you can ensure you come away with the tools to gain meaningful results. • Join leading academic and industry experts, Professor Tudor Arvinte, Uni

Résumé: IQPC’s Pharma IQ’s Biobanking conference will show professionals working in Labs, Biorepositories, Bioanalysis and R&D how to set up productive biological sample management efforts; including assessing the latest automation systems; how to accurately assess samples including DNA, Blood and Human tissues; understand and work with Regulations and Bioethical challenges; and effectively collect and manage patient information.

Résumé: During our workshop we would like to present the most recent research in the field of single molecule spectroscopy.

Résumé: The conference objective is to showcase research and development activities in Biotechnology and Bioinformatics:

Research and development in biotechnology requires the collaboration of scientists and engineers in fields such as biology, chemistry, computer science, chemical engineering, and bio engineering. This conference brings together scientists, engineers and scholars from relevant fields with practitioners from industry in order to help each group to understand progress made in the area as a whole.

Résumé: Completing the sequence of human and other genomes will soon elucidate the precise location and base sequence of every gene in a reference genome. This reference allows for rapid characterization of polymorphisms across populations. It also enables molecular fingerprinting technologies to permit identification of the precursors and consequences of normal and pathological changes in gene expression. The challenge facing current biological research is effective matching of the tool to the target. Learn from seasoned and savvy researchers who share their experience and of challenges piecing together the biological puzzle of health and disease at Cambridge Healthtech Institute’s 4th Annual Genomic Tools: Targeting the Missing Links between Health and Disease. www.healthtech.com

Résumé: Chemokines are a family of approximately 50 proteins that differ from other cytokines in that they act on G protein-coupled seven transmembrane (7TM) spanning receptors. Their principal role is to direct leukocyte trafficking in the body, and they are thus pivotal to development and the establishment of the immune system. However their excessive activity results in the establishment of inflammation. Through studies in animal models using tools such as genetically modified mice, neutralizing antibodies and receptor antagonists, they have been shown to play a role in diseases such as asthma, atherosclerosis, multiple sclerosis, inflammatory bowel disorder and arthritis, as well as many others. They are also involved in diseases such as cancer and infectious diseases such as AIDS, where they play a role beyond inflammation. Their involvement in the CNS and in apoptosis also demonstrates activity beyond cell recruitment. Since 7TM receptors are one of the cornerstones for drug discovery, they provide a very attractive target for therapeutic intervention, and programs are now moving into the clinic, with the first approval by the FDA achieved in 2007. They are also suitable targets for biological therapeutics, and again monoclonal antibodies are currently being tested in clinical trials.

Résumé: As new sequencing platforms are capable of generating gigabytes of data in a single sequence run - leading to terabytes of data in an experiment; data storage, transfer, and analysis will unquestionably be the rate limiting steps in turning the new sequence data into knowledge. CHI’s Inaugural Next-Generation Sequencing Data Analysis convenes engineers who are developing the sequencing platforms, biological researchers who are designing and running the experiments, biosatiations who are analyzing and interpreting the data, and software developers who are managing and storing the data. Each specialty provides perspectives and must be integrated into a cohesive, comprehensive team to decipher the sequencing data deluge. www.healthtech.com

Résumé: The conference will focus on rapidly developing areas of science in which chemists and other researchers can enhance current biology or even build completely new biological systems. It aims to play a leading role in bringing together the multidisciplinary community that will drive forward tomorrow's bioscience research.

Résumé: Gene Acres is a one-day facilities conference featuring timely analysis of issues by professionals from multiple perspectives. From facilities design to security, and from regulatory certification to international operations, Gene Acres conference provides insights into the challenges faced by life science companies every day. A closing reception will provide a perfect opportunity to network with your peers.

* What: 16th Annual Gene Acres Conference

* When: 8:30am - 5:30pm, Wednesday, September 24, 2008

* Where: South San Francisco Conference Center, 255 South Airport Blvd., South San Francisco, CA. Directions.

* Attire: Business Attire Suggested

* Present at the 16th Annual Gene Acres Conference - Submit a Session!

* Conference Sponsorship Opportunities

* Media Registration

Résumé: Genomic research has become a discipline to be integrated with clinical medicine. Currently, genomic technologies allow for the simultaneous quantification of gene activity in tissues/cells from patients. Will these genomic technologies make it possible to develop personalized medicine leading to a more accurate diagnosis and prognosis for every patient and subsequently a tailored treatment strategy? With the addition and linkage of clinical parameters disparate data points are created. All agree data integration is crucial. Join innovators from technological platform development, biostatistical analysis, biological, pharmaceutical, and clinical research as they share their experiences and insights for Integrative Data Analysis: Is Personalized Medicine at Hand? www.healthtech.com

Résumé: Next-Generation sequencing is alive, thriving, and driving discovery. As costs come down and ease increases these new massively parallel high-throughput sequencing platforms are infiltrating multiple aspects of traditional biological research. However, each next generation sequencing platform best lends itself to specific sequencing goals. Cambridge Healthtech Institute’s Exploring Next Generation Sequencing offers an unparalleled opportunity to compare and contrast these next generation sequencing platforms to best suit your research needs. www.healthtech.com

Résumé: The dynamic of biological systems is a general and important topic to understand structure and function of life processes. The workshop addresses recent aspects of biomolecular dynamics in the context of neutron scattering experiments. This includes the controversial discussion concerning the mechanism of the dynamical transition, the role of hydration water, proteins in extreme environments, collective motions, biological function and simulation of neutron scattering spectra.

The workshop provides a forum, where all groups working in the field, can present their point of view.

Résumé: •Fourth Annual Genomic Biomarkers •Sixth Annual Protein Biomarkers •Ninth Annual Metabolic Biomarkers www.BiomarkerDiscoverySummit.com

Résumé: Systems Chemistry is the joint effort of prebiotic and supramolecular chemistry together with theoretical biology and complex systems research to address problems relating to the synthesis of life. The emerging field can be viewed as the bottom up pendant of systems biology towards synthetic biology. A major focus is laid on the study of autocatalytic reaction systems, such as chemical self-replicating, self-reproducing, and chiral symmetry breaking systems. The field aims at the construction of dynamic supersystems embedding at least one autocatalytic subsystem. Subsystems may be classified as genetic, metabolic, or compartiment-building. Pairwise integration into higher organized supersystems is expected to yield the knowledge enabling later the triple integration into minimal chemical cells. Finding the chemical roots of Darwinian evolvability is seen as a key challenge for the field.

The conference will convene internationally leading experts from various relevant areas to elucidate where we stand in 2008. Facets from this intriguing and truly interdisciplinary endeavour come from fields as diverse as geochemistry and organocatalysis, biomolecular chemistry and liposome technology, metal-organic chemistry and the theory of networks and evolution. Joining these facets by the unifying principle of autocatalysis leads to a new view which may be especially attractive for the next generation of chemists.

Résumé: The TriMark Molecular Diagnostics Conference 2008 has been organized to provide a critical examination of the molecular diagnostics industry, as well as insight from key industry leaders concerning cutting edge molecular diagnostics technology, structuring mutually beneficial deals and the molecular diagnostics industry’s impact on the field of in vitro diagnostics. This conference will also provide an integral forum for leaders in molecular diagnostics, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new molecular diagnostics technologies.

Résumé: Generating and interpreting molecular interaction data is hard enough, however, properly applying that information to aid drug discovery and development is an even bigger challenge. Are you aware of the multitude of molecular interactions that affect biotherapeutics? Gain a better understanding of PK Assay strategies to support non-clinical and clinical studies.Which drug species should be measured and why? Could you use tools and strategies for development of novel Antibody-Drug Conjugates (ADCs)? Join us to discuss some of the fundamental biochemical underpinnings of bioanalytical assays, as well as to hear case studies describing assays and how they addressed particular bioanalytical questions.

*Understand and Apply Molecular Interactions

*Current PK Assay Strategies

*Bioanalytical Strategies for Antibody-Drug Conjugates

*Assessment of Fc Functionality

This exciting premiere event is the first time all of these critical componen

Résumé: This annually organized international event provides detailed information on research & development and the latest advancement in the biotechnology industry. This year, BioMalaysia 2008 is expected to attract more than 10,000 visitors and 1,800 delegates locally and internationally. During the event, there will be collaborations of activities between exhibitors and visitors that will lead to new business openings, partnerships and joint-ventures within and across industries.

Résumé: BIT's Bio-Venture Capital Forum is the echo of successful and fruitful 'Summer Davos' 2007, it is committed to a comprehensive, coordinated and sustainable path of biotechnology development. Bio-VC is the place where bio venture and high tech companies in & outside China present their unique technologies to professionals around the world.

Résumé: Bench2Boardroom is now clearly established as the event for the UK's biotech and medtech communities. Once again, delegates benefited from an update on services, products and best practice as well as peer to peer networking and expert advice. The online facility available prior to the event was extremely popular this year, allowing individuals to capitalise on their Bench2Boardroom day by pre-planning their personal agendas and one to one meetings.

Bench2Boardroom 2008 will be held on 15 October 2008, at Chilford Hall.

Résumé: The American Biological Safety Association (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners of biological safety, and to provide a forum for the continued and timely exchange of biosafety in formation.

ABSA accomplishes these goals by publishing and distributing a quarterly journal, Applied Biosafety and a number of other biosafety publications. ABSA also conducts an annual Biological Safety Conference to keep members informed of current biosafety issues and regulatory initiatives. The conference is preceded by a selection of biosafety courses geared at the beginner and advanced levels. In addition, ABSA produces an annual membership directory to stimulate networking.

ABSA offers a registration (Registered Biosafety Professional) and certification (Certifi

Résumé: The TriMark Stem Cell Conference 2008 has been organized to provide a critical examination of the stem cell industry, as well as insight from key industry leaders concerning cutting edge stem cell technology, structuring mutually beneficial deals and the stem cell industry’s impact on the field of regenerative medicine and drug discovery. This conference will also provide an integral forum for leaders in stem cell research centers and laboratories to share ideas, network with other delegates and advance understanding of the potential of stem cell technology.

Résumé: This Congress and Expo is organized by BITlifesciences, dedicated to building a platform of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technology. CEMD-2008 will also provide an integral forum for leaders in trends of MD, in major diseases treatment to share ideas, network with other delegates, deliver new products and advance understanding of the potential of new molecular diagnostics technologies.

Résumé: This Congress and Expo is organized by BIT life sciences, dedicated to build a platform of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technology. CEMD-2008 will also provide an integral forum for leaders in trends of MD, in major diseases treatment to share ideas, network with other delegates, deliver new products and advance understanding of the potential of new molecular diagnostics technologies.

Résumé: Europe’s Leading Bioprocessing Event for the Manufacture of Biologics

Résumé: The ESF Research Conferences Scheme provides the opportunity for leading scientists and young researchers to meet for discussions on the most recent developments in their fields of research. It acts as a catalyst for creating new synergistic contacts throughout Europe and the rest of the world. It develops principally through the establishment of long-term partnerships between the ESF and national and international organisations, including universities.

Résumé: A workshop on the science and practical issues of small animal imaging will be held at Stanford on November 5-8, 2008. The workshop will cover new commercially available small animal imaging systems (optical, radionuclide, x-ray, magnetic resonance, and ultrasound) and how researchers use these small animal imaging systems to study the molecular basis of disease noninvasively and aid in the discovery, development, and monitoring of novel molecular-based treatments.

Résumé: The 14th annual BIO-Europe event is the world’s largest dedicated biotechnology partnering conference. Over 2,200 global decision-makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system, enabling delegates from all parts of the biotechnology value-chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe is the preeminent partnering conference for the life sciences. BIO-Europe brings together international decision-makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop & panel participation, a high-level exhibition, and private, pre-scheduled one-to-one meetings. Delegates from all parts of the biotechnology value-chain come to BIO-Europe to quickly identify, engage and enter into st

Résumé: BITlifesciences is now organizing the 'World Gene Industry Congres 2008' which will be held during 2008 in Guangzhou, China. It will be a major congress, sharing the Revolutionary developments in life sciences since the discovery of the double helix and setting the stage for the advancement of biology and medicine in the 21 st century. This congress will promote the Gene technology development and collaboration world wide.

Résumé: Following the successful outcome and encouraging results of the 1st congress, we are proud to announce the 2nd congress to continually promote the developments of gene science and technology. The aim of this conference is to build up an ideal platform to exchange ideas with your colleagues, to make new acquaintances and to familiarize yourself with the most recent science and technology in the flourishing filed of genome.

Résumé: Conference invites participants from all over the world to present their research in all areas related to Environmental BioTechnology. Venue of conference is Gangtok-sheer magic of the world. About 1000 delegates are expected to participate in this prestigious conference. Last date of submission of abstracts is 30th September 2008 along with early registration fees.